Old Web
English
Sign In
Acemap
>
authorDetail
>
Joy Ero
Joy Ero
Novartis
Medicine
single agent
Breast cancer
Targeted therapy
Pathology
2
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC).
2015
Journal of Clinical Oncology
Payal Deepak Shah
Sarat Chandarlapaty
Maura N. Dickler
Gary A. Ulaner
Stephen Zamora
Valentina Sterlin
Alexia Iasonos
Christina Coughlin
Alex Morozov
Joy Ero
Neal Rosen
Teresa Gilewski
Monica Fornier
Nancy Sklarin
Michael F. Berger
Mary Ellen Moynahan
Clifford A. Hudis
José Baselga
Shanu Modi
Show All
Source
Cite
Save
Citations (18)
Successful implementation of a novel trial model: The Signature program.
2015
Journal of Clinical Oncology
Julio Antonio Peguero
James A. Knost
Todd Michael Bauer
Matthew H. Taylor
Fadi S. Braiteh
Joseph Paul Eder
Howard Safran
Bert H. O'Neil
Ajjai Alva
Lincoln Nadauld
Prashant Joshi
Flora Miranda
Rajinder Sidhu
Joy Ero
Eric Daniel Slosberg
C. Lebedinsky
Barinder Kang
Sudha Parasuraman
Sarina Anne Piha-Paul
Show All
Source
Cite
Save
Citations (9)
1